iih and glp 1 Metabolic Concepts in Idiopathic Intracranial Hypertension Their Potential for Therapeutic Intervention neurologist discusses the role of
Description
2025 Jan;27(1):1-9
Nutrition & diabetes , 3 (6), e78-e78
rescue use) and employment of combination strategies with multi-agonist incretin therapies and/or anabolic/anti-catabolic agents
doi: 10.1016/S0140-6736(21)01324-6 Summary Keywords glucagon, GLP-1, obesity, co-agonist, weight loss Citation Hope DCD, Vincent ML and Tan TMM (2021) Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
impact on molecular structure and half-life
I wanted to see how my body responded and I was also scared about the potential side effects since I tend to be sensitive toward medications
